Physician-led longevity care
Before choosing care, you may want to know why a test or next step is being considered. Here we explain the evidence behind the approach, its limits and the questions you can ask a physician.
A measurement, its interpretation and a treatment outcome answer different questions. A model may identify a pattern, but that alone does not show that a treatment helps people. We examine what a method measures, whether the interpretation is justified, whether the explanation is accurate, whether the process is safe and what changed for the people studied.
Healthy Longevity Clinic was a 2025 XPRIZE Healthspan Milestone 1 award recipient. Its eight-week proof-of-concept used the same care logic that guides our client programs: measure the starting point, coordinate a personalized multimodal program and measure again. Several measures showed statistically significant pre/post improvements within that short window. The study was small and uncontrolled, so the results are an encouraging signal rather than a promise of an individual outcome.
Positive, unchanged and adverse findings belong in the same account, together with duration, population and measurement method. A short summary must preserve the qualification that makes a result understandable.
A physician considers the relevance and strength of evidence for your circumstances. A method, a research finding and a service available at a location are distinct things. Explore the evidence policy before interpreting a scientific statement as a care promise.
How we present evidence
Clinical judgment should be accountable to the evidence and clear about its limits.
Model validity: does the model measure what it claims? Interpretation method: are the conclusions drawn appropriately? Content accuracy: is the explanation faithful to the evidence? Workflow safety: are safeguards working? Outcomes: what changed for people, under which conditions? Evidence for one question is not proof of another.
When a result is published, the account identifies the population, duration, method and relevant limitations. Model-estimated years do not represent calendar years gained. A multimodal evaluation cannot establish which individual component caused a change.
Clinical eligibility and recommendations are independent of price, relationship level and investment interests. Where scientific or investment affiliations are discussed, the relationship and its limits must be visible.
Medical content is prepared for named authorship, physician review and dated revisions. If you would like to question a statement or request its source, contact the clinic. Publication status should be explicit wherever a report is not yet available.
Evidence labels
The strength of the evidence and the regulatory status of a use answer different questions. Both matter.
In this proposed framework, Established means strong human evidence supports the specific claim in the relevant population and context. Emerging means human evidence is early, limited or inconsistent. Routine use alone does not establish evidence strength. Each label must identify the supporting evidence and its limits.
Use status is recorded separately for the relevant jurisdiction. For an approved medicine, off-label use is outside its approved terms, such as the condition, dose or route; it is not an evidence-strength rating. Investigational status has its own legal and oversight requirements and does not establish routine availability. This website does not offer access to an investigational intervention.
A label does not establish personal suitability, availability at a clinic or an expected benefit for you. Those decisions require the relevant evidence and clinical assessment.
A physician explains what a method can tell you, what remains uncertain and how it could change your care.
